Immune Design Corporation to Present at 3rd Annual Cancer Immunotherapy Conference
10/3/2012 9:54:50 AM
SEATTLE, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Immune Design today announced that the company will be presenting at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality conference on Thursday, October 4, at 3:15 p.m. ET, at the New York Academy of Medicine. Immune Design's President and Chief Executive Officer, Carlos Paya, M.D., Ph.D., will provide an overview of the Company's immunotherapy platform technologies and planned product pipeline.